BIM
bioMérieux is a global leader in in vitro diagnostics, developing, producing and delivering diagnostic tests that help clinicians diagnose infections, monitor antimicrobial resistance, ensure food safety, and support pharmaceutical quality control. With a long history dating back to 1963, the company serves hospital laboratories, point-of-care settings, and the food safety and quality sectors, delivering rapid, accurate results that improve patient outcomes and public health. The German-language pages highlight a local presence in Germany while emphasizing its worldwide mission to advance diagnostic solutions and education for healthcare professionals.
No recent deals for this company.